Bio Rad Laboratories Inc (BIO) Stock Analysis
Verdict: HOLD
Elliott Management's activist stake provides a definitive catalyst to unlock value from the Sartorius holding and improve dismal margins.
Investment score: 64/100
Analysis as of
Is Bio Rad Laboratories Inc stock worth reviewing? The TradeMates thesis
Bio-Rad is an operational turnaround story wrapped in a complex holding company structure. Activist pressure is the key to unlocking hidden value.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 75/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 70/100 (weight 10%)
- Risk-Adjusted Return: 65/100 (weight 15%)
Bio Rad Laboratories Inc opportunities and risks
What speaks for BIO
- Activist-Driven Margin Expansion
What speaks against BIO
- Governance Friction with Schwartz Family
Frequently asked questions about Bio Rad Laboratories Inc (BIO)
Is BIO stock a good investment?
The TradeMates model rates Bio Rad Laboratories Inc as HOLD with an investment score of 64/100. Bio-Rad is an operational turnaround story wrapped in a complex holding company structure. Activist pressure is the key to unlocking hidden value. This is algorithmic model output, not personal investment advice.
Is BIO stock a buy?
The TradeMates model verdict for BIO is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.